Follow
Mattis Ranthe, MD, PhD
Mattis Ranthe, MD, PhD
Unknown affiliation
Verified email at ssi.dk
Title
Cited by
Cited by
Year
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study
C Rungoe, S Basit, MF Ranthe, J Wohlfahrt, E Langholz, T Jess
Gut 62 (5), 689-694, 2013
2052013
Familial aggregation of lone atrial fibrillation in young persons
N Øyen, MF Ranthe, L Carstensen, HA Boyd, MS Olesen, SP Olesen, ...
Journal of the American College of Cardiology 60 (10), 917-921, 2012
1582012
Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy
I Behrens, S Basit, JA Lykke, MF Ranthe, J Wohlfahrt, H Bundgaard, ...
Jama 315 (10), 1026-1033, 2016
1442016
Pregnancy loss and later risk of atherosclerotic disease
MF Ranthe, EAW Andersen, J Wohlfahrt, H Bundgaard, M Melbye, ...
Circulation 127 (17), 1775-1782, 2013
1142013
Rare truncating variants in the sarcomeric protein titin associate with familial and early-onset atrial fibrillation
G Ahlberg, L Refsgaard, PR Lundegaard, L Andreasen, MF Ranthe, ...
Nature communications 9 (1), 4316, 2018
1032018
Risk of cardiovascular disease in family members of young sudden cardiac death victims
MF Ranthe, BG Winkel, EW Andersen, B Risgaard, J Wohlfahrt, ...
European heart journal 34 (7), 503-511, 2013
912013
Family history of premature death and risk of early onset cardiovascular disease
MF Ranthe, L Carstensen, N Øyen, J Tfelt-Hansen, M Christiansen, ...
Journal of the American College of Cardiology 60 (9), 814-821, 2012
762012
Cardiac involvement in myotonic dystrophy: a nationwide cohort study
M Lund, LJ Diaz, MF Ranthe, H Petri, M Duno, I Juncker, H Eiberg, ...
European heart journal 35 (32), 2158-2164, 2014
682014
Hypertensive disorders of pregnancy and peripartum cardiomyopathy: a nationwide cohort study
I Behrens, S Basit, JA Lykke, MF Ranthe, J Wohlfahrt, H Bundgaard, ...
PloS one 14 (2), e0211857, 2019
522019
A detailed family history of myocardial infarction and risk of myocardial infarction–a nationwide cohort study
MF Ranthe, JA Petersen, H Bundgaard, J Wohlfahrt, M Melbye, HA Boyd
PLoS One 10 (5), e0125896, 2015
492015
Superior HbA1c control with the fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with a maximum dose of 50 units of insulin degludec in Japanese …
H Watada, S Kaneko, M Komatsu, BR Agner, T Nishida, M Ranthe, ...
Diabetes, Obesity and Metabolism 21 (12), 2694-2703, 2019
282019
Risk of cardiomyopathy in younger persons with a family history of death from cardiomyopathy: a nationwide family study in a cohort of 3.9 million persons
MF Ranthe, L Carstensen, N Øyen, MK Jensen, A Axelsson, J Wohlfahrt, ...
Circulation 132 (11), 1013-1019, 2015
252015
Superior efficacy with a fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) compared with insulin degludec and liraglutide in insulin‐naïve Japanese …
K Kaku, E Araki, Y Tanizawa, B Ross Agner, T Nishida, M Ranthe, ...
Diabetes, Obesity and Metabolism 21 (12), 2674-2683, 2019
222019
Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based …
B Pasternak, H Svanström, MF Ranthe, M Melbye, A Hviid
CNS drugs 28, 963-973, 2014
222014
Association between pregnancy losses in women and risk of atherosclerotic disease in their relatives: a nationwide cohort study
MF Ranthe, LJ Diaz, I Behrens, H Bundgaard, J Simonsen, M Melbye, ...
European Heart Journal 37 (11), 900-907, 2016
172016
Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial
I Lingvay, S Harris, E Jaeckel, K Chandarana, MF Ranthe, E Jódar
Diabetes, Obesity and Metabolism 20 (1), 200-205, 2018
162018
IDegLira improves glycemic control in Japanese patients with uncontrolled type 2 diabetes on premixed insulin therapy
H Watada, BF Ross Agner, A Doshi, L Bardtrum, MF Ranthe, LK Billings
Diabetes Therapy 11, 331-339, 2020
152020
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: a DEVOTE subanalysis (DEVOTE 10)
K Brown‐Frandsen, SS Emerson, DK McGuire, TR Pieber, NR Poulter, ...
Diabetes, Obesity and Metabolism 21 (6), 1437-1444, 2019
152019
Persistence with IDegLira in patients in clinical practice: a nationwide observational study in Sweden
B Eliasson, J Ekelund, M Miftaraj, MF Ranthe, AC Mårdby, ...
Diabetes Therapy 11, 1807-1820, 2020
102020
Insulin degludec/liraglutide (ID egLira) maintains glycaemic control and improves clinical outcomes, regardless of pre‐trial insulin dose, in people with type 2 diabetes that …
L Meneghini, A Doshi, D Gouet, T Vilsbøll, K Begtrup, P Őrsy, MF Ranthe, ...
Diabetic Medicine 37 (2), 267-276, 2020
92020
The system can't perform the operation now. Try again later.
Articles 1–20